Corteva, Inc. CTVA SPX
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -0.1% CAGR over 5 years.
- Earnings shrank at -1.6% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CTVA Corteva, Inc. SPX | 78.28 | 42.31 | $52.36B | 0.92% | 6.08% | 5.14% | -0.10% | -1.56% |
| 2 | LIN Linde plc NDXSPX | 497.69 | 33.00 | $230.11B | 1.29% | 13.07% | 18.23% | 0.62% | 18.48% |
| 3 | NEM Newmont Corporation SPX | 109.81 | 14.24 | $117.23B | 0.95% | 22.51% | 25.83% | 23.91% | 583.84% |
| 4 | FCX Freeport-McMoRan Inc. SPX | 65.71 | 34.77 | $94.46B | 0.91% | 12.93% | 15.63% | 4.39% | -14.02% |
| 5 | SHW The Sherwin-Williams Company SPX | 303.84 | 29.16 | $74.94B | 1.05% | 20.04% | 60.72% | 2.10% | 8.34% |
| 6 | CRH CRH plc SPX | 108.79 | 20.18 | $72.69B | 1.43% | 11.33% | 15.81% | 4.60% | -1.15% |
| 7 | ECL Ecolab Inc. SPX | 256.00 | 34.59 | $72.05B | 1.14% | 14.89% | 22.43% | 4.26% | 23.88% |
| 8 | APD Air Products and Chemicals, Inc. SPX | 278.62 | 29.33 | $62.04B | 2.60% | -0.62% | 12.35% | -1.77% | -39.16% |
| 9 | NUE Nucor Corporation SPX | 250.00 | 24.80 | $56.94B | 0.90% | 8.80% | 12.29% | -7.84% | -38.80% |
Quarterly Results
Figures in USD.
| Metric | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.79B | 5.73B | 1.95B | 2.81B | 3.40B | 5.56B | 1.91B | 2.98B | 3.96B | 5.19B | 1.86B | 3.21B | 4.18B | 5.63B | 2.37B | 4.60B | 6.25B | 2.78B | 4.88B | 6.04B | 2.59B | 4.49B | 6.11B | - | - | 4.42B | 6.46B | 2.62B | 3.91B | 4.91B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.34B | 2.93B | 1.64B | 2.25B | 2.37B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.08B | 3.52B | 974.00M | 1.66B | 2.53B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.25B | 1.69B | 1.24B | 1.41B | 1.38B |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 827.00M | 1.83B | -270.00M | 242.00M | 1.16B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.12B | 2.16B | -24.00M | -178.00M | 1.19B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 36.00M | 52.00M | 46.00M | 46.00M | 36.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 784.00M | 1.80B | -370.00M | -530.00M | 858.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 117.00M | 422.00M | -62.00M | 7.00M | 133.00M |
| Net Income | -107.00M | 694.00M | -5.12B | -531.00M | 164.00M | -608.00M | -494.00M | -21.00M | 272.00M | 760.00M | -392.00M | 41.00M | 600.00M | 970.00M | 30.00M | 564.00M | 969.00M | -331.00M | 595.00M | 714.00M | -321.00M | 419.00M | 1.05B | - | - | 652.00M | 1.31B | -320.00M | -552.00M | 720.00M |
| Diluted EPS | - | 0.92 | -6.83 | - | 0.22 | -0.81 | -0.66 | - | 0.36 | 1.01 | -0.52 | - | 0.80 | 1.31 | 0.04 | 0.78 | 1.33 | -0.46 | 0.83 | 1.00 | -0.45 | 0.60 | 1.51 | - | - | 0.95 | 1.92 | -0.47 | -0.82 | 1.07 |
| R&D Expense | 382.00M | 354.00M | 325.00M | - | 299.00M | 269.00M | 289.00M | - | 280.00M | 273.00M | 284.00M | - | 281.00M | 293.00M | 297.00M | 268.00M | 296.00M | 312.00M | 316.00M | 329.00M | 335.00M | 332.00M | 357.00M | 348.00M | - | 335.00M | 375.00M | 351.00M | - | 341.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.29B | 13.85B | 14.22B | 15.65B | 17.45B | 17.23B | 16.91B | 17.40B |
| Cost of Revenue | - | - | - | - | 10.44B | 9.92B | 9.53B | 9.17B |
| Gross Profit | - | - | - | - | 7.02B | 7.31B | 7.38B | 8.23B |
| Operating Expenses | - | - | - | - | 5.09B | 5.20B | 5.28B | 5.61B |
| Operating Income | - | - | - | - | 1.93B | 2.11B | 2.10B | 2.62B |
| EBITDA | - | - | - | - | 2.73B | 2.54B | 2.73B | 3.07B |
| Interest Expense | - | - | - | - | 79.00M | 233.00M | 233.00M | 180.00M |
| Pretax Income | - | - | - | - | 1.43B | 1.09B | 1.27B | 1.69B |
| Tax Provision | - | - | - | - | 210.00M | 152.00M | 412.00M | 484.00M |
| Net Income | -5.07B | -959.00M | 681.00M | 1.76B | 1.15B | 735.00M | 907.00M | 1.09B |
| Diluted EPS | -6.76 | -1.28 | 0.91 | 2.37 | 1.58 | 1.03 | 1.30 | 1.60 |
| R&D Expense | 1.35B | 1.15B | 1.14B | 1.19B | 1.22B | 1.34B | 1.40B | 1.47B |
Compounded Sales Growth
| 5 Years: | -0.10% |
| 1 Year: | 11.00% |
Compounded Profit Growth
| 5 Years: | -1.56% |
| 1 Year: | 12.10% |
Stock Price Performance
| 1 Year: | +11.65% |
| 6 Months: | +19.10% |
| 3 Months: | -2.08% |
| 1 Month: | -1.37% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2016 | Aug 2017 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | - | 108.68B | 42.40B | 42.65B | - | 42.62B | 43.00B | 40.83B | 42.84B |
| Current Assets | - | - | - | - | - | - | - | 16.80B | 16.26B | 15.10B | 17.34B |
| Cash & Equivalents | - | - | - | 2.27B | 1.76B | 3.53B | - | 3.19B | 2.64B | 3.11B | 4.52B |
| Inventory | - | - | - | - | - | - | - | 6.81B | 6.90B | 5.43B | 5.67B |
| Receivables | - | - | - | - | - | - | - | 4.26B | 4.33B | 4.62B | 5.03B |
| Total Liabilities | - | - | - | - | - | - | - | 17.08B | 17.72B | 16.80B | 18.46B |
| Current Liabilities | - | - | - | 13.31B | 8.24B | 8.55B | - | 10.74B | 10.41B | 10.39B | 12.12B |
| Long Term Debt | - | - | - | - | - | - | - | 1.28B | 2.29B | 1.95B | 1.69B |
| Total Debt | - | - | - | - | - | - | - | 1.31B | 2.49B | 2.70B | 2.58B |
| Total Equity | 10.20B | 12.52B | 79.59B | 74.66B | 24.31B | 24.82B | - | 25.30B | 25.04B | 23.79B | 24.14B |
| Shares Outstanding | - | - | - | - | - | - | - | 713.42M | 701.26M | 685.60M | 672.16M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 483.00M | 1.07B | 2.06B | - | 872.00M | 1.77B | 2.15B | 3.41B |
| Investing Cash Flow | -505.00M | -904.00M | -674.00M | - | -632.00M | -1.99B | -589.00M | -543.00M |
| Financing Cash Flow | -2.62B | -2.93B | 303.00M | - | -1.18B | -99.00M | -1.20B | -1.64B |
| Capital Expenditure | -1.50B | -1.16B | - | - | -605.00M | -595.00M | -597.00M | -591.00M |
| Free Cash Flow | -1.02B | -93.00M | - | - | 267.00M | 1.17B | 1.55B | 2.81B |
| Net Change in Cash | - | - | - | - | -940.00M | -317.00M | 357.00M | 1.22B |
| Share Buybacks | 0 | 25.00M | 275.00M | 950.00M | 1.00B | 756.00M | 1.01B | 1.07B |
| Dividends Paid | 0 | -194.00M | -388.00M | 397.00M | 418.00M | 439.00M | 458.00M | 475.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | 40.2% | 42.4% | 43.6% | 47.3% |
| Operating Margin % | - | - | - | - | 11.0% | 12.2% | 12.4% | 15.1% |
| Net Margin % | -35.5% | -6.9% | 4.8% | 11.2% | 6.6% | 4.3% | 5.4% | 6.3% |
| ROE % | -6.8% | -3.9% | 2.7% | - | 4.5% | 2.9% | 3.8% | 4.5% |
| ROCE % | - | - | - | - | 6.0% | 6.5% | 6.9% | 8.5% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 8.18% | 54.71M | $4.28B |
| 2 | Vanguard Capital Management LLC | 6.59% | 44.08M | $3.45B |
| 3 | State Street Corporation | 5.40% | 36.14M | $2.83B |
| 4 | Capital World Investors | 5.38% | 36.00M | $2.82B |
| 5 | FMR, LLC | 5.23% | 34.97M | $2.74B |
| 6 | Vanguard Portfolio Management LLC | 4.49% | 30.06M | $2.35B |
| 7 | Franklin Resources, Inc. | 3.26% | 21.79M | $1.71B |
| 8 | Aristotle Capital Management, LLC | 2.82% | 18.83M | $1.47B |
| 9 | Geode Capital Management, LLC | 2.80% | 18.72M | $1.47B |
| 10 | Harris Associates L.P. | 2.49% | 16.66M | $1.30B |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CTVA